Lataa...
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
The frequency of using rituximab to treat refractory nephrotic syndrome has recently been increasing, and the conventional dose of rituximab used to treat it, 375 mg/m2 body surface area once weekly for 4 weeks, has been modelled on the chemotherapy regimen for B-cell non-Hodgkin’s lymphoma. The dos...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Karger Publishers
2018-10-01
|
| Sarja: | Case Reports in Nephrology and Dialysis |
| Aiheet: | |
| Linkit: | https://www.karger.com/Article/FullText/493189 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|